Indoor Air Quality Monitor for Smoking Cessation
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests whether an indoor air quality monitor (AirGradient ONE) can help cancer patients quit smoking by maintaining smoke-free homes. The focus is on patients who currently smoke and participate in a tobacco treatment program. Eligible participants must be cancer patients who smoke, have completed an initial counseling session in the program, and have Wi-Fi at home. The trial aims to determine if tracking indoor air quality can support smoking cessation efforts. As an unphased trial, this study provides a unique opportunity for patients to contribute to innovative research that may enhance their journey to quit smoking.
Do I need to stop taking my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications. It focuses on using an air quality monitor to help quit smoking, so it's best to ask the trial coordinators for more details.
What prior data suggests that this indoor air quality monitor is safe for use in smoking cessation?
Research has shown that the AirGradient ONE indoor air quality monitor is highly accurate, particularly in detecting harmful particles like PM2.5 and other air pollutants. Safety standards such as CE and FCC have tested and approved the device, confirming it meets strict safety and quality guidelines.
As a monitor rather than a medication, the device poses no direct health risks to users. Its purpose is to track indoor air quality, serving as a safe tool for promoting a smoke-free home. No reports of negative effects from its use have been documented.12345Why are researchers excited about this trial?
The Indoor Air Quality Monitor AirGradient ONE is unique because it offers a tech-driven approach to smoking cessation by directly monitoring and improving indoor air quality. Unlike traditional methods like nicotine replacement therapies or medications that target cravings, this device provides real-time data on air pollutants, potentially motivating smokers to reduce their smoking habits by making them more aware of the impact on their environment. Researchers are excited about this trial because it explores a novel, non-invasive way to encourage smoking cessation by leveraging environmental feedback rather than chemical interventions.
What evidence suggests that using an indoor air quality monitor is effective for promoting a smoke-free home?
Research has shown that using an indoor air quality monitor can encourage people to smoke less indoors. Although these monitors did not significantly increase the number of people who quit smoking altogether, they did help some change their smoking habits. In this trial, participants will use the AirGradient ONE monitor, which provides real-time updates on air quality. This allows users to see how smoke affects their surroundings, and this visual feedback can strongly motivate smokers to reduce or stop smoking indoors. Early findings suggest this method could help promote smoke-free homes, especially for those receiving assistance to quit smoking.12367
Who Is on the Research Team?
Gleneara Bates-Pappas, PhD, LMSW
Principal Investigator
Memorial Sloan Kettering Cancer Center
Are You a Good Fit for This Trial?
This trial is for cancer patients trying to quit smoking and are enrolled in MSK's Tobacco Treatment Program. It aims to see if using an air quality monitor helps them keep their homes smoke-free.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants use an indoor air quality monitor and attend smoke-free workshop sessions
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Indoor Air Quality Monitor AirGradient ONE
Find a Clinic Near You
Who Is Running the Clinical Trial?
Memorial Sloan Kettering Cancer Center
Lead Sponsor